Jonathan Chung to Poly(ADP-ribose) Polymerase Inhibitors
This is a "connection" page, showing publications Jonathan Chung has written about Poly(ADP-ribose) Polymerase Inhibitors.
Connection Strength
0.741
-
Exceptional response to olaparib in BRCA2-altered urothelial carcinoma after PD-L1 inhibitor and chemotherapy failure. Eur J Cancer. 2018 06; 96:128-130.
Score: 0.595
-
BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy. Clin Breast Cancer. 2018 04; 18(2):184-188.
Score: 0.146